Lv5
980 积分 2021-01-04 加入
Dynamic T‐Cell Reprogramming Modulates the Treatment Outcome of Neoadjuvant Immunochemotherapy in Non‐Small‐Cell Lung Cancer
12天前
已完结
Multi-omic profiling highlights factors associated with resistance to immuno-chemotherapy in non-small-cell lung cancer
12天前
已完结
A single-cell atlas reveals immune heterogeneity in anti-PD-1-treated non-small cell lung cancer
12天前
已完结
Diagnostic Utility of microRNA146a and microRNA19a in Gallbladder Cancer: A Pilot Study
1个月前
已完结
Clinical significance of circulatory microRNA-183_5p and 3651 in serum as novel potential diagnostic marker for gallbladder cancer
1个月前
已完结
Chemoradiation Reprograms Tumor Cells and the Immune Microenvironment in Cervical Cancer
3个月前
已完结
Longitudinal Profiling of Cervical Cancers Reveals Therapy-Induced Vulnerabilities Beyond the Checkpoint
3个月前
已完结
Multiomic analysis of cervical squamous cell carcinoma identifies cellular ecosystems with biological and clinical relevance
3个月前
已完结
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial
3个月前
已完结
First-Line Pembrolizumab + Chemotherapy Versus Placebo + Chemotherapy for Persistent, Recurrent, or Metastatic Cervical Cancer: Final Overall Survival Results of KEYNOTE-826
3个月前
已完结
皖公网安备34019202002308
